Big News| Grand Opening Ceremony of 2019 Chinese Medicinal Chemistry Symposium &CPA-EFMC International Symposium on Medicinal Chemistry
Open the phone and scan
On August 16, 2019, the 2019 Chinese Medicinal
Chemistry Symposium (CMCS 2019) &CPA-EFMC International Symposium on
Medicinal Chemistry sponsored by Chinese Pharmaceutical Association (CPA),
undertaken by State Key Laboratory of Biotherapy and Pharmaceutical College of
Sichuan University, and co-organized by Sichuan International Medical Exchange
& Promotion Association were held in Chengdu, Sichuan Province.
Sun Xianze, president of CPA, Sun Yanrong,
vice director of CNCBD, Xu Weilin, vice-president of Sichuan University, Zhang
Lihe, academician of Peking University School of Pharmaceutical Science, Chen
Kaixian, academician of Shanghai Institute of Meteria Medica, Chinese Academy
of Sciences, Yang Shengyong, professor of College of Chemistry, Sichuan
University, Zou Weiping, professor University of Michigan, the US, Dr
Yves Patrick Auberson, president of European Federation For Medicinal Chemistry
( EFMC), Dr Antoni Torrens Jover, dean of EFMC, and other world-famous
pharmaceutical chemical experts and enterprises attended the ceremony. Wei
Yuquan, academician of Chinese Academy of Sciences, director of State Key
Laboratory of Biotherapy of Sichuan University, president of Sichuan
International Medical Exchange & Promotion Association attended the
Symposium and gave keynote speech.
The theme of the Symposium was "focus on
new targets, new technologies, new molecules, boost the original drug research
and development and transformation". The topic of CPA-EFMC International
Symposium on Medicinal Chemistry was "exploring new approaches to tumor
immunotherapy", which included hot issues such as artificial intelligence
and drug molecular design, new methods and processes of drug synthesis, and
frontier fields of pharmaceutical chemistry. The Symposium attracted nearly
2500 delegates from universities, research institutes, hospitals and
pharmaceutical R&D enterprises in Chinese Mainland, Hong Kong, Macao and
Taiwan, as well as pharmaceutical chemistry representatives from the UK, the
US, Japan and other countries. In the following 3 days, they shared
cutting-edge research results in the field of pharmaceutical chemistry and
exchanged their experiences from basic research to industrialization.
Professor Yang shengyong, executive chairman
of the conference, served as host of the opening ceremony of the Symposium. He
grandly presented the experts on site and warmly welcomed the participants and
media representatives from afar.
In the presentation part, Wei Yuquan,
academician of Chinese Academy of Sciences, president of Sichuan International
Medical Exchange & Promotion Association shared the research progress of
tumor microenvironment and biological targeted therapy. He said genomics has
brought new opportunities for tumor immunotherapy and gene therapy, and
mentioned the application of immune cell therapy, CAR-T cell therapy, tumor
protein or peptide vaccine to individual treatment of tumor patients.
At the conference, academician Chen Kaixian
delivered speech as the Symposium chairman. Since the establishment of Chinese
Medicinal Chemistry Symposium, the highest-level scientific event in the field
of medicinal chemistry research in China, the number of participants has
continued to expand, the exchange and cooperation platform has gradually
improved, and academic influence has deepened, said academician Chen. The
Symposium was unprecedented in scale, with more than 2500 people registered and
more than 260 academic reports, which fully reflected the vigorous development
of the field of pharmaceutical chemistry in China and the strong momentum to
forge ahead. The Symposium played an important role in analyzing and discussing
the development trend of medicinal chemistry in China and grasping the
development trend of international disciplines. It would definitely lay a solid
foundation for improving the level of drug research and innovation in China,
promoting the healthy development of pharmacy disciplines, and providing scientific
research power.
Chen Kaixian, academician of Chinese Academy
of Sciences
In the speech, professor Xu Weilin, vice
president of Sichuan University, said that Chinese Medicinal Chemistry
Symposium was the highest-level scientific gathering in the field of
pharmacochemistry research in China. The theme and topic of each session were
very cutting-edge and innovative. The successful convening of the Symposium
would be conducive to further dissemination of cutting-edge knowledge in the
field of pharmaceutical chemistry, further defining the direction and tasks of
the future development of new drugs, and further promoting international
academic exchanges and cooperation in pharmaceutical chemistry.
Sun Yanrong, vice director of CNCBD, pointed
out in her speech that in 2018, CNCBD was entrusted by the department of major
projects to jointly carry out research on the development of major new drugs by
2035 and the continuation of major national science and technology projects.
Our country has made great progress in the development of new drugs, and we
have truly realized the historic transformation from imitation to combination
of creation and imitation, and then to innovation. In the future, we should
continue to place the development of new drugs in an important historical
position and support the development of this field with more persistent and
stable central finance. The Symposium would definitely improve our innovation
capability and self-confidence, so that we can work together to bring the
dreams of every scientist and every entrepreneur together to realize the dream
of new drug development. By 2035, China is sure to make greater progress in new
drug development.
Sun Yanrong, vice director of CNCBD,
Then, Sun Xianze, president of CPA and deputy
director general of State Food and Drug Administration (SFDA) gave speech.
President Sun said that CPA has been developing for 112 years and become a
scientific and technological group with extensive influence in the
pharmaceutical field at home and abroad. In the future, it would continue to
lead people in the pharmaceutical industry to carry out in-depth academic exchanges,
make unremitting efforts to promote the development of pharmaceutical industry
in China, maintain public health, and make new contributions to the prosperity
and development of pharmaceutical industry in China. In the meanwhile,
president Sun also stressed that China marked the 70th anniversary of the
founding of the People's Republic of China this year, a crucial year for
securing the first centenary goal of building a moderately prosperous society
in all respects. We should stick to the idea put forward by general secretary
Xi that innovation is the primary driving force and talents are the primary
resource, implement the strategy of innovation-driven development, improve the
national innovation system, accelerate independent innovation in key and core
technologies, and create new introduction for economic and social development.
In addition, president Sun Xianze highly praised Sichuan provincial government
and Chengdu municipal government for issuing a series of supporting policies on
promoting the healthy development of pharmaceutical industry, including
implementation opinions, rewards and incentives, and achievement
transformation. They strive to build Chengdu into a world-class medical and
health industry highland, accelerate the construction of a world-class
trillion-level modern medical industry system with international
competitiveness and regional driving force.
Then, in the 2019 Annual Award Ceremony of Servier
Pharmaceutical Chemistry, Ms. Gao Man, sales director of Servier China, pointed
out that the original intention of "CPA - Servier young
pharmaceutical chemistry award" sponsered by Servier and CPA has never
changed. Servier and CPA would jointly promote the prosperity and development of
pharmaceutical science and technology, promote the growth and improvement of
pharmaceutical talents, and promote the combination and transformation of
pharmaceutical science and technology and industry, so as to ultimately serve
the patients.
Gao Man, sales director of Servier China
Academician Zhang Lihe, chairman of academic
board, announced the winners of Servier pharmaceutical chemistry award. In his
speech, he especially thanked Servier research institute for its contribution
to the development of pharmaceutical industry in China and sincerely welcomed
continue cooperation. He also pointed out that the implementation of national
innovation-driven development strategy has brought rare opportunities for the
development of pharmaceutical research. The research and development of
innovative drugs have broad prospects. With the optimization of domestic policy
environment, the increase of capital injected into the pharmaceutical industry
and the return of high-tech talents, the innovation in drugs in China has huge
potential space and future development impetus. There is still a long way to go
for China's original drug research and development and transformation. It needs
the joint efforts of all research and development staff to seize the
opportunity, speed up innovation and build a stronger international
competitiveness of China's pharmaceutical industry with independent
intellectual property rights.
Sector of awarding, professor Ouyang Liang
from State Key Laboratory of Biotherapy of Sichuan University, a member unit of
Sichuan International Medical Exchange & Promotion Association won the 2019
Servier award for medicinal chemistry.
Group photo ( the fourth on the right is
professor Ouyang Liang)
Annex: the highlights of the opening ceremony
